Yifan Wu Selected Research

yishen

1/2020	Bupi Yishen Formula Versus Losartan for Non-Diabetic Stage 4 Chronic Kidney Disease: A Randomized Controlled Trial.
9/2015	Rationale and design of the Helping Ease Renal failure with Bupi Yishen compared with the Angiotensin II Antagonist Losartan (HERBAAL) trial: a randomized controlled trial in non-diabetes stage 4 chronic kidney disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yifan Wu Research Topics

Disease

34	Neoplasms (Cancer) 05/2024 - 01/2016
15	Infections 04/2024 - 01/2021
14	Inflammation (Inflammations) 03/2024 - 01/2019
10	Osteoarthritis 12/2023 - 01/2019
8	Stroke (Strokes) 01/2024 - 01/2020
6	Breast Neoplasms (Breast Cancer) 02/2024 - 01/2019
6	Hepatocellular Carcinoma (Hepatoma) 01/2024 - 01/2017
6	Cardiovascular Diseases (Cardiovascular Disease) 01/2024 - 10/2019
5	Lung Neoplasms (Lung Cancer) 05/2024 - 01/2020
5	Kashin-Beck Disease 12/2023 - 01/2022
5	Wounds and Injuries (Trauma) 01/2023 - 04/2014
5	Chronic Renal Insufficiency 06/2022 - 09/2015
4	Liver Neoplasms (Liver Cancer) 03/2024 - 01/2018
4	Type 2 Diabetes Mellitus (MODY) 01/2024 - 06/2018
4	Ischemia 09/2023 - 01/2017
4	Ischemic Stroke 09/2023 - 01/2021
4	Neoplasm Metastasis (Metastasis) 06/2023 - 06/2017
4	Ovarian Neoplasms (Ovarian Cancer) 09/2020 - 06/2017
3	Neuromyelitis Optica (Devic's Disease) 01/2024 - 03/2019
3	Metabolic Diseases (Metabolic Disease) 12/2023 - 02/2023
3	Obesity 12/2023 - 01/2023
3	Non-alcoholic Fatty Liver Disease 11/2023 - 12/2019
3	Insulin Resistance 01/2023 - 11/2022
3	Dementia (Dementias) 01/2023 - 06/2018
3	Cognitive Dysfunction 01/2023 - 06/2018
3	Neuroinflammatory Diseases 11/2022 - 03/2019
3	Stomach Neoplasms (Stomach Cancer) 05/2022 - 11/2016
3	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022 - 07/2015
3	Hypoxia (Hypoxemia) 01/2021 - 09/2016
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2024 - 07/2017
2	Gestational Diabetes (Gestational Diabetes Mellitus) 02/2024 - 10/2023
2	Myocardial Infarction 01/2024 - 09/2023
2	Diabetic Nephropathies (Diabetic Nephropathy) 10/2023 - 01/2013
2	Pathologic Processes 09/2023 - 05/2006
2	Hemorrhage 09/2023 - 01/2021
2	Reperfusion Injury 09/2023 - 01/2021
2	Fibrosis (Cirrhosis) 05/2023 - 10/2022
2	Diarrhea 01/2023 - 01/2022
2	Crush Injuries 01/2023 - 09/2022
2	Hepatitis B 01/2023 - 10/2022
2	Pneumonia (Pneumonitis) 01/2023 - 10/2021
2	Parkinson Disease (Parkinson's Disease) 01/2023 - 11/2022
2	Major Depressive Disorder (Major Depressive Disorders) 01/2023 - 01/2023
2	Epilepsy (Aura) 01/2023 - 11/2022
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 11/2022 - 01/2021
2	Bacterial Infections (Bacterial Infection) 09/2022 - 03/2020
2	Infarction (Infarctions) 05/2022 - 01/2021

Drug/Important Bio-Agent (IBA)

20	Proteins (Proteins, Gene)FDA Link 05/2024 - 09/2015
10	Biomarkers (Surrogate Marker)IBA 02/2024 - 02/2020
9	RNA (Ribonucleic Acid)IBA 01/2024 - 01/2019
7	Glucose (Dextrose)FDA LinkGeneric 01/2024 - 01/2018
7	Anti-Bacterial Agents (Antibiotics)IBA 06/2023 - 03/2020
6	MicroRNAs (MicroRNA)IBA 12/2023 - 06/2017
6	LipidsIBA 11/2023 - 01/2020
5	Peptides (Polypeptides)IBA 11/2023 - 01/2019
5	Cisplatin (Platino)FDA LinkGeneric 05/2022 - 11/2016
5	CytokinesIBA 01/2021 - 11/2018
4	Messenger RNA (mRNA)IBA 01/2024 - 01/2019
4	AntibodiesIBA 11/2023 - 01/2018
4	Circular RNAIBA 11/2023 - 01/2022
4	InflammasomesIBA 10/2023 - 01/2021
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2023 - 01/2021
3	Triglycerides (Triacylglycerol)IBA 01/2024 - 01/2023
3	CopperIBA 01/2024 - 11/2023
3	SeleniumIBA 12/2023 - 01/2023
3	Indocyanine Green (Cardio-Green)FDA LinkGeneric 09/2023 - 01/2022
3	Interleukin-4 (Interleukin 4)IBA 08/2023 - 01/2019
3	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 01/2019
3	Interleukin-6 (Interleukin 6)IBA 01/2023 - 06/2022
3	Lactic Acid (Lactate)FDA LinkGeneric 11/2022 - 01/2018
3	Long Noncoding RNAIBA 01/2022 - 06/2021
3	Immunoglobulin E (IgE)IBA 10/2021 - 01/2019
3	Therapeutic UsesIBA 03/2021 - 10/2017
3	Caspase 3 (Caspase-3)IBA 01/2021 - 10/2017
2	Oxidoreductases (Dehydrogenase)IBA 05/2024 - 01/2021
2	Apolipoproteins E (ApoE)IBA 04/2024 - 06/2018
2	Immune Checkpoint InhibitorsIBA 04/2024 - 01/2022
2	N-methyladenosineIBA 01/2024 - 11/2023
2	6-methyladenineIBA 01/2024 - 12/2023
2	SodiumIBA 01/2024 - 01/2020
2	Glucagon-Like Peptide-1 Receptor AgonistsIBA 01/2024 - 12/2023
2	T-2 Toxin (T 2 Toxin)IBA 12/2023 - 06/2023
2	Immunoglobulin G (IgG)IBA 11/2023 - 10/2021
2	NF-kappa B (NF-kB)IBA 09/2023 - 05/2006
2	Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA 01/2023 - 01/2023
2	VaccinesIBA 01/2023 - 03/2022
2	C-Reactive ProteinIBA 01/2023 - 02/2014
2	HydrogelsIBA 01/2023 - 09/2022
2	MelatoninIBA 01/2023 - 03/2021
2	Insulin (Novolin)FDA Link 11/2022 - 10/2022

Therapy/Procedure

20	Therapeutics 04/2024 - 11/2016
8	Drug Therapy (Chemotherapy) 11/2023 - 09/2016
5	Immunotherapy 04/2024 - 01/2019
4	Photochemotherapy (Photodynamic Therapy) 04/2024 - 10/2017
4	Precision Medicine 11/2023 - 10/2017
2	Radiotherapy 08/2023 - 01/2022
2	Neck Dissection (Radical Neck Dissection) 05/2023 - 02/2023
2	Transplantation 11/2022 - 01/2022
2	Transjugular Intrahepatic Portasystemic Shunt 10/2022 - 01/2021
2	Surgical Portasystemic Shunt (Portosystemic Shunt) 10/2022 - 01/2021